Original title: Evening News: Haidilao’s 2021 performance forecast loss exceeds 3.8 billion Asymchem received 3.542 billion supply orders
Author: sunny
Haidilao: Net loss is expected to be regarding 3.8 billion to 4.5 billion yuan in 2021
Haidilao announced on the Hong Kong Stock Exchange that it is expected to record a net loss of approximately RMB 3.8 billion to RMB 4.5 billion for the year ending December 31, 2021. Month-on-month revenue in 2020 is approximately RMB 28.6 billion, and the group’s revenue in 2021 is expected to exceed RMB 40 billion, an increase of more than 40%. Regarding the reasons for the expected loss, Haidilao said that the restaurant operation in the second half of 2021 was significantly affected by the global and regional outbreaks and public health control measures, resulting in a decline in the operating performance of Haidilao Restaurant in the second half of 2021 compared with the same period in 2020. . Overseas stores will experience increased losses in 2021. (China Fund News)
Asymchem received 3.542 billion yuan in supply orders
Asymchem released an announcement announcing that the company continued to provide contract custom development and production (CDMO) services for a small molecule chemical innovative drug of a pharmaceutical company. Recently, Jilin Asymchem Pharmaceutical Chemical Co., Ltd., a wholly-owned subsidiary of the company, signed a contract with the customer A new batch of “Supply Contracts” for related products, the contract value is equivalent to RMB 3.542 billion, and the new supply contract has officially come into effect. Asymchem said that the performance of the contract will have a positive impact on the company’s operating income and operating profit in 2022. (Beijing News)
Chengda Pharmaceutical responded to the letter of concern saying that it did not cooperate with Pfizer on Paxlovid
Chengda Pharmaceutical announced in response to the Shenzhen Stock Exchange’s letter of concern that it has not cooperated with Pfizer on Paxlovid-related intermediates. (Daily Economic News)
Kangtai Bio-Inactivated New Crown Vaccine Approved Homologous Booster Immunization
The Joint Prevention and Control Mechanism of the State Council approved the homologous booster immunization of Shenzhen Kangtai Bio’s new coronavirus inactivated vaccine. This means that the target population who has been vaccinated with Kangtai Bio’s new coronavirus inactivated vaccine can receive one dose of homologous booster immunization, that is, boosting with the original vaccine. Research data show that both homologous booster immunization and sequential booster immunization can further improve the immune effect. (Securities Times)
Tencent Music’s application for Metaverse trademark was rejected
The Tianyancha App shows that recently, the status of multiple “Rhythm Metaverse” trademarks applied by Tencent Music Entertainment Technology (Shenzhen) Co., Ltd., an affiliate company of National K song, has been changed to “waiting for rejection review”. The international classification includes sales, scientific instruments, Education and entertainment, etc., trademark application in September 2021. However, the trademark status of Tencent Technology (Shenzhen) Co., Ltd. for registration of QQ Metaverse, Tianyuan Universe, and King Metaverse is still under application. (First Finance and Economics)
Weibo responds to “layoffs”: some organizations are making adjustments and core key businesses are still recruiting
Financial Associated Press reported on February 21 that some netizens who were certified as Weibo employees publicly stated that Weibo is undergoing large-scale layoffs, and some employees have even been asked to leave voluntarily. The relevant person in charge of Weibo said that the company took stock of the business at the beginning of the year. In order to strengthen the advantageous areas and business focus, some organizations were adjusted to promote efficient collaboration and organizational vitality. In this adjustment, the company prioritized the adjustment of employees involved. If there is no suitable post, negotiate to terminate the labor relationship, make economic compensation according to the law, and try to provide assistance for re-employment. In addition, the recruitment of many core key businesses of the company has been progressing normally, and there is no layoff. (The Paper)
Hosun Silicon Industry: Hosun Group’s accumulative pledged shares are regarding 190 million shares
Hesheng Silicon Industry announced that the controlling shareholder Ningbo Hesheng Group Co., Ltd. directly holds regarding 547 million shares of the company, accounting for 50.89% of the company’s total share capital. After this pledge, Hoshine Group has pledged regarding 190 million shares in total, accounting for 34.83% of its shares and 17.73% of the company’s total share capital. As of the date of this announcement, Hopson Group and its persons acting in concert, Luo Liguo, Luo Yi, and Luo Yedong, directly hold approximately 821 million shares of the company (of which approximately 685 million are unrestricted tradable shares), accounting for the total share capital of the company. of 76.44%. After this pledge, the accumulative number of pledged shares in the company’s shares directly held by Hesheng Group and its concerted actors Luo Liguo, Luo Yi, and Luo Yedong is approximately 292 million shares, accounting for 292 million shares of the company’s total shares held by them. 35.53%, accounting for 27.16% of the company’s total share capital.
Suao Sensing received the 97.34 million yuan bid winning notice from Xiaopeng Motors
Suao Sensing issued an announcement stating that the company received the “Notice of Winning the Bid” from Guangzhou Xiaopeng Automobile Technology Co., Ltd. (hereinfollowing referred to as “Xpeng Automobile”). The winning project is a platform project of Xiaopeng Motors. The total winning amount of the above project is RMB 97.34 million, accounting for 11.97% of the company’s audited operating income in 2020. If a formal contract can be signed and implemented smoothly, it will have a positive impact on the company’s future operating performance. (Shanghai Securities News)Return to Sohu, see more
Editor:
Disclaimer: The opinions of this article only represent the author himself, Sohu is an information publishing platform, and Sohu only provides information storage space services.